Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Wells Fargo analyst Derek Archila initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight rating and announces Price Target of $5.
Wells Fargo analyst Derek Archila initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight rating and announces Price Target of $5.